Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, ottobre 30
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Nuvation Bio Inc
NUVB
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$4.77
0.18
3.92%
Ult. Agg.: Oct 29, 7:35 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 tra 6 giorni da adesso in mer nov 4th, dopo la chiusura del mercato
Conference call:
Conference call programmata per tra 6 giorni alle 4:30 PM
Clicca per vedere il webcast
Nuvation Bio Financials
Nuvation Bio (NUVB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Nuvation Bio Q2 EPS $(0.18) Beats $(0.19) Estimate, Sales $31.687M Beat $27.505M Estimate
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 5.88 percent decrease over losses of $(0.17) per share from the
Benzinga Newsdesk
PRO
Nuvation Bio Q1 EPS $0.01, Inline, Sales $83.228M Beat $62.259M Estimate.
Nuvation Bio (NYSE:NUVB) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is a 106.25 percent increase over losses of $(0.16) per share from the same period last year. The
Benzinga Newsdesk
Earnings Scheduled For May 4, 2026
Benzinga Insights
Earnings Breakdown: Nuvation Bio Q4
Benzinga Insights
PRO
Nuvation Bio Q4 EPS $(0.11) Misses $(0.09) Estimate, Sales $41.865M Beat $37.326M Estimate
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 26.67 percent increase over losses of $(0.15) per share from the
Benzinga Newsdesk
Earnings Scheduled For March 2, 2026
Benzinga Insights
